Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Orthopedic Devices Panel Rejects Stryker’s OP-1 Putty For Spinal Fusion

This article was originally published in The Gray Sheet

Executive Summary

FDA's Orthopedic and Rehabilitation Devices advisory panel voted 6-1 to recommend against approval of Stryker Biotech's OP-1 Putty spinal fusion product March 31

Related Content

Olympus Acquires Stryker OP-1 Products, Spawns Biotech Division
Medicare Advisors Set To Meet On BMPs; AHRQ Tech Assessment Issued
Stryker Wraps Up Last Of FDA Warning Letters, Pledges To Retain QSR Focus
Evidence On Off-Label Bone Morphogenetic Protein Benefit Is Limited
Zimmer Leans On Hip/Knee Sales As Spine Business Continues Decline In Q4
Stryker Unit Charged With Fraud, Misbranding For Illegal Marketing Scheme
Stryker Knee Sales Capped By Economic Downturn; Firm Lowers ’09 Guidance
A Last Gasp for Stryker with OP-1? Not Likely.
Stryker Spine Putty Approval “Significantly” Delayed, Firm Says
Stryker Spine Putty Approval “Significantly” Delayed, Firm Says





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts